{"Abbreviation":"PMA","Aliases":["4-Methoxyamphetamine","para-methoxyamphetamine","1-p-Methoxyphenyl-2-aminopropane","2-Amino-1-(4'-methoxyphenyl)propane","P-methoxyamfetamine","4-methoxyamfetamine","(+-)-p-Methoxyamphetamine","p-Methoxy-α-methylphenethylamine","DEATH","benzeneethanamine, 4-methoxy-α-methyl-"],"CAS":"64-13-1","ChEMBL":"CHEMBL278663","ChemicalClasses":["amphetamine"],"Chirality":"racemic","DEA no":7411,"Dosing Info":[],"DrugClasses":["hallucinogens"],"EINECS":"200-577-0","European Community (EC) Number":"200-577-0","HMDB ID":"HMDB0246494","HeavyAtomCount":12,"IUPACName":"1-(4-methoxyphenyl)propan-2-amine","InChI":"InChI=1S/C10H15NO/c1-8(11)7-9-3-5-10(12-2)6-4-9/h3-6,8H,7,11H2,1-2H3","InChIKey":"NEGYEDYHPHMHGK-UHFFFAOYSA-N","MeSH Pharmacological Classification":"Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise. (See all compounds classified as Hallucinogens.)","MolecularFormula":"C\u003csub\u003e10\u003c/sub\u003eH\u003csub\u003e15\u003c/sub\u003eNO","MolecularWeight":"165.23 g/mol","Opticalactivity":"( + / - )","PrevSalts":[],"PubChemId":31721,"Record Description":["4-methoxyamphetamine is a DEA Schedule I controlled substance. Substances in the DEA Schedule I have no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse. It is a Hallucinogenic substances substance.","4-Methoxyamphetamine has been reported in Senegalia berlandieri with data available.","para-Methoxyamphetamine (PMA; \"Death\", \"Dr. Death\"), also known as 4-methoxyamphetamine (4-MA), is a designer drug of the amphetamine class with serotonergic effects. Unlike other similar drugs of this family, PMA does not produce stimulant, euphoriant, or entactogen effects, and behaves more like an antidepressant in comparison,[citation needed] though it does have some psychedelic properties.","Wikipedia|List of designer drugs|Empathogens|Amphetamines","Wikipedia|PiHKAL|Phenethylamines"],"References":[{"Name":"Wikipedia","Urls":[{"Link":"https://en.wikipedia.org/wiki/Para-Methoxyamphetamine","Name":"Paramethoxyamphetamine","Sub":false}]},{"Name":"Wikidata","Urls":[{"Link":"https://www.wikidata.org/wiki/Q230005","Name":"Paramethoxyamphetamine","Sub":false}]},{"Name":"DrugBank","Urls":[{"Link":"https://go.drugbank.com/drugs/DB01472","Name":"Paramethoxyamphetamine","Sub":false}]},{"Name":"PubChem","Urls":[{"Link":"https://pubchem.ncbi.nlm.nih.gov/compound/31721","Name":"Paramethoxyamphetamine","Sub":false}]},{"Name":"ChemSpider","Urls":[{"Link":"https://www.chemspider.com/Chemical-Structure.29417.html","Name":"Paramethoxyamphetamine","Sub":false}]},{"Name":"ChEMBL","Urls":[{"Link":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL278663","Name":"Paramethoxyamphetamine","Sub":false}]},{"Name":"Common Chemistry","Urls":[{"Link":"https://commonchemistry.cas.org/detail?cas_rn=64-13-1","Name":"Paramethoxyamphetamine","Sub":false}]},{"Name":"HMDB","Urls":[{"Link":"https://hmdb.ca/metabolites/HMDB0246494","Name":"Paramethoxyamphetamine","Sub":false}]},{"Name":"KEGG","Urls":[{"Link":"https://www.kegg.jp/entry/C22811","Name":"Paramethoxyamphetamine","Sub":false}]},{"Name":"UNII","Urls":[{"Link":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/OVB8F8P39Q","Name":"Paramethoxyamphetamine","Sub":false}]},{"Name":"EPA DSSTox","Urls":[{"Link":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID7040578","Name":"Paramethoxyamphetamine","Sub":false}]}],"SMILES":"CC(CC1=CC=C(C=C1)OC)N","Slang":["Death ","Chicken Powder ","Chicken Yellow "],"StereoisomerRacemic":"(RS)-Paramethoxyamphetamine","StoreUNII":["OVB8F8P39Q"],"StructureBase64":"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","Therapeutic Uses":"Hallucinogens","Title":"Paramethoxyamphetamine","UNII":"OVB8F8P39Q","Wikidata":"Q230005","XLogP":1.8}